RepliCel Life SciencesのEPS 1株当たり利益
RepliCel Life SciencesのEPS 1株当たり利益 は何ですか。
RepliCel Life Sciences, Inc.のEPS 1株当たり利益 は-0.01です。
EPS 1株当たり利益 の定義は何ですか。
1株当たり利益（EPS) は、当社の1株当たり利益です。それは株式の希釈を考慮に入れ、 過去12ヶ月間にカウントされます。
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
TSXVのセクタHealth CareにおけるEPS 1株当たり利益 の企業と比べるRepliCel Life Sciences
RepliCel Life Sciencesは何をしますか。
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.
RepliCel Life Sciencesと類似のeps 1株当たり利益
- RespiriのEPS 1株当たり利益 は-0.01です。
- Carespan Health IncのEPS 1株当たり利益 は-0.01です。
- China Environmental Technology and BioenergyのEPS 1株当たり利益 は-0.01です。
- Aurora Solar TechnologiesのEPS 1株当たり利益 は-0.01です。
- Tanzanian GoldのEPS 1株当たり利益 は-0.01です。
- SynertecのEPS 1株当たり利益 は-0.01です。
- RepliCel Life SciencesのEPS 1株当たり利益 は-0.01です。
- Ming LamのEPS 1株当たり利益 は-0.01です。
- GME ResourcesのEPS 1株当たり利益 は-0.01です。
- Super StrongのEPS 1株当たり利益 は-0.01です。
- Fintech SelectのEPS 1株当たり利益 は-0.01です。
- Summit AscentのEPS 1株当たり利益 は-0.01です。
- New City DevelopmentのEPS 1株当たり利益 は-0.01です。